The association of HLA-DR13 with lower graft survival rates in hepatitis B and primary sclerosing cholangitis Caucasian patients receiving a liver transplant

Liver Transplantation

Volumn 12, Issue 4, 2006, Pages 600-604

  Futagawa, Yasuro ^a   Waki, Kayo ^a   Cai, Junchao ^a  

^a TERASAKI FOUNDATION LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA DR13 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS B; HUMAN; IMMUNE RESPONSE; KAPLAN MEIER METHOD; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNITED STATES;

BIOLOGICAL MARKERS; CHOLANGITIS, SCLEROSING; EUROPEAN CONTINENTAL ANCESTRY GROUP; GRAFT SURVIVAL; HEPATITIS B; HLA-DR ANTIGENS; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33645536822     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20678     Document Type: Article

References (16)

1. Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Gruner N, et al. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998;113:244-251.
2. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 1999;53:459-469.
3. Donaldson PT, Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol 2001;15:611-627.
4. Cullen S, Chapman R. Primary sclerosing cholangitis. Autoimmun Rev 2003;2:305-312.
5. Kim WR, Poterucha JJ, Kremers WK, Ishitani MB, Dickson ER. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004;10:968-974.
6. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991;352:595-600.
7. Kuzushita N, Hayashi N, Katayama K, Hiramatsu N, Yasumaru M, Murata H, et al. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J Med Virol 1996;48:1-7.
8. Chen Y, Winchester R, Korber B, Gagliano J, Bryson Y, Hutto C, et al. Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: Association of several HLA-DR13 alleles with long-term survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS. Long-term survivor study. Hum Immunol 1997;55:154-162.
9. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between a MHC class II alle and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065-1069.
10. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, et al. HLA-DRB1*1301 and 1302 protect against chronic hepatitis B. J Hepatol 1997;26:503-507.
11. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000;31:1371-1373.
12. Cao T, Desombere I, Vanlandschoot PV, Sallberg M, Leroux-Roels G. Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B. J Gen Virol 2002; 83:3023-3033.
13. Hastings AE, Hurley CK, Robinson ED, Salerno K, Hernandez E, Richert JR. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptid 152-165, and HLA-DR13. J Immunol 1996; 157:3460-3471.
14. Vierling JM. Aetiopathogenesis of primary sclerosing cholangitis. In: Manns PCR, Stieihl A, Wiesner R, eds. Primary Sclerosing Cholangitis. London: Kluwer Academic Publishers; 1998:9.
15. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451-457.
16. Oertel M, Berr F, Schroder S, Schwarz R, Tannapfel A. Wenzke M, et al. Acute rejection of hepatic allografts from HLA-DR13(allele DRB1*1301)-positive donors. Liver Transpl 2000;6:728-733.